Millennium Management
KYMR icon

Millennium Management’s Kymera Therapeutics KYMR Stock Holding History

Millennium Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,243
Closed -$875K – 6060
2025
Q4 		$875K Sell
11,243
-83,718
-88% -$5.65M ﹤0.01% 4573
2025
Q3 		$5.37M Buy
94,961
+38,425
+68% +$1.73M ﹤0.01% 3071
2025
Q2 		$2.47M Sell
56,536
-453,944
-89% -$15.6M ﹤0.01% 3693
2025
Q1 		$14M Buy
510,480
+394,562
+340% +$14.4M 0.01% 1858
2024
Q4 		$4.66M Buy
115,918
+77,912
+205% +$3.52M ﹤0.01% 2876
2024
Q3 		$1.8M Buy
38,006
+19,720
+108% +$871K ﹤0.01% 3789
2024
Q2 		$546K Sell
18,286
-34,766
-66% -$1.2M ﹤0.01% 4532
2024
Q1 		$2.13M Sell
53,052
-45,244
-46% -$1.62M ﹤0.01% 3676
2023
Q4 		$2.5M Sell
98,296
-73,615
-43% -$1.32M ﹤0.01% 3419
2023
Q3 		$2.39M Buy
171,911
+116,710
+211% +$2.35M ﹤0.01% 3390
2023
Q2 		$1.27M Buy
+55,201
New +$1.58M ﹤0.01% 3844
2022
Q4 		– Sell
-69,085
Closed -$1.84M – 6815
2022
Q3 		$1.5M Buy
+69,085
New +$1.82M ﹤0.01% 3997
2021
Q2 		– Sell
-127,727
Closed -$4.96M – 6818
2021
Q1 		$4.96M Buy
+127,727
New +$7.69M ﹤0.01% 2582
2020
Q4 		– Sell
-16,008
Closed -$517 – 5409
2020
Q3 		$517 Buy
+16,008
New +$489K ﹤0.01% 3563

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Millennium Management's KYMR Position: Q1 2026 in Review

Millennium Management sold out of Kymera Therapeutics (KYMR) in Q1 2026, closing a stake of 11,243 shares — an estimated $875K sold.

Millennium Management first reported a position in KYMR in Q3 2020 and held it in 14 quarters. The position peaked at $14M in Q1 2025. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Millennium Management reported no remaining Kymera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 11,243 Kymera Therapeutics shares in Q1 2026, an estimated $875K.
  • Millennium Management first reported a position in Kymera Therapeutics in Q3 2020 and held it in 14 quarters.
  • Millennium Management's Kymera Therapeutics position peaked at $14M in Q1 2025.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.